Metropolis Healthcare Ltd announced a 15.3% increase in PAT for Q3FY25, with a 10.9% YoY growth amounting to INR 323 Cr, and EBITDA growth of 17.8%. The report noted significant revenue growth driven by strong patient volume and expansions in the TruHealth and Specialty segments.